Polaris Group Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Steve Hsu
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.0003% |
Management average tenure | less than a year |
Board average tenure | no data |
Recent management updates
Recent updates
CEO
Steve Hsu
less than a year
Tenure
Dr. Steve J.P. Hsu serves as Chairman and Chief Executive Officer of Genovior Biotech Corporation. Dr. Hsu has been Chief Executive Officer of Polaris Group since December 21, 2023.Dr. Hsu has over extens...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | less than a year | no data | 0.00027% NT$ 141.3k | |
President | no data | no data | no data | |
Chief Financial Officer | no data | no data | no data | |
Chief Operating Officer | less than a year | no data | 0.00067% NT$ 350.7k | |
Chief Strategy Officer | less than a year | no data | no data | |
Chief Information Security Officer | less than a year | no data | no data |
0.7yrs
Average Tenure
Experienced Management: 6550's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.